NCT05723861

Brief Summary

This project will use a randomized controlled trial to test the effect of using Virtual Reality on pain, anxiety, patients' comfort, and satisfaction during colonoscopy. Patients will use a virtual reality head-mounted display and choose a visualized VR content to watch during colonoscopy. Colonoscopy will be initiated without standard sedatives and narcotics and using virtual reality distraction for as long as the patient would like (for a maximum of 20 minutes). Participants could opt out and/or request standard medications for pain at any time before or during the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

February 13, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

March 22, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2023

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2023

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

3 months

First QC Date

January 20, 2023

Last Update Submit

June 29, 2023

Conditions

Keywords

ColonoscopyVirtual RealityAnxietyPainPatient comfort

Outcome Measures

Primary Outcomes (7)

  • Patient pain before colonoscopy procedure

    Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

    5 - 15 minutes before starting colonoscopy.

  • Patient pain during colonoscopy procedure

    Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

    During the colonoscopy procedure (from the time colonoscopy is started until ended).

  • Patient pain after colonoscopy procedure

    Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

    5 - 15 minutes after the colonoscopy is ended.

  • Patient anxiety before colonoscopy procedure

    Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.

    5 - 15 minutes before starting colonoscopy.

  • Patient anxiety after colonoscopy procedure

    Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.

    5 - 15 minutes after the colonoscopy is ended.

  • Patient comfort during colonoscopy procedure

    Patient comfort will be measured by a nurse/researcher using the five-point Modified. Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).

    During the colonoscopy procedure (from the time colonoscopy is started until ended).

  • Patient comfort after colonoscopy procedure

    Patient comfort will be measured by a nurse/researcher using the five-point Modified. Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).

    5 - 15 minutes after the colonoscopy is ended.

Secondary Outcomes (2)

  • Patient satisfaction

    5 - 15 minutes after the colonoscopy is ended.

  • Patient / healthcare professional experience with using VR during colonoscopy

    30 minutes - one week after the procedure

Study Arms (2)

VR group

EXPERIMENTAL

Participants will receive Virtual Reality intervention in addition to routine care during colonoscopy.

Device: VR

Control group

NO INTERVENTION

Receive routine treatment.

Interventions

VRDEVICE

We will use the Pico Headset, a three-dimensional Gear with a connected tablet, and will be positioned on the head with elastic straps. Patients will be instructed about the VR device before their procedure and virtual experiences will initiate just before colonoscope insertion and continuously delivered throughout the procedure for max of 20 minutes. Patients will experience max of 20 minutes of VR and if colonoscopy lasts longer than 20 min, the remaining time of colonoscopy will be performed without using VR. The visualized content of VR will be chosen by the participants among three available contents including beach, nature, or mountain with relaxing music. Participants could opt out and/or request standard medications for pain at any time before or during the procedure.

VR group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥ 18
  • any elective indication of colonoscopy

You may not qualify if:

  • having visual impairments,
  • having dementia
  • limited Danish language skills
  • a high tendency to travel sickness
  • having skin disease in the facial area
  • having epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology, Herlev and Gentofte Hospital

Copenhagen, 2730, Denmark

Location

Related Publications (1)

  • Shamali M, Vilmann P, Johansen NR, Konradsen H. Virtual reality intervention to improve quality of care during colonoscopy: a hybrid type 1 randomized controlled trial. Gastrointest Endosc. 2024 Nov;100(5):914-922.e2. doi: 10.1016/j.gie.2024.05.023. Epub 2024 Jun 6.

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mahdi Shamali, PhD

    Herlev and Gentofte University Hospital

    PRINCIPAL INVESTIGATOR
  • Hanne Konradsen, PhD

    Herlev and Gentofte University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoc Researcher

Study Record Dates

First Submitted

January 20, 2023

First Posted

February 13, 2023

Study Start

March 22, 2023

Primary Completion

June 14, 2023

Study Completion

June 28, 2023

Last Updated

July 3, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations